Upload
phamnhu
View
217
Download
0
Embed Size (px)
Citation preview
1
LE PROFESSIONI DEL BIOLOGO E DEL BIOTECNOLOGOIncontri di preparazione dedicati agli studenti e ai neolaureati dei Corsi di Laurea in Biologia e Biotecnologie
Il Biologo e il Biotecnologocome controller e collaboratore nella Ricerca Clinica
Luca Faoro
Sr Trial Operation Manager
Global Drug Development, Novartis
Facoltà di Scienze e Tecnologie
Dipartimento di Bioscienze
Università degli Studi di Milano - 8 Novembre 2018
2
Preliminary statement
This presentation represent my own opinion
and does not necessarily
reflect Novartis’ opinion/view
3
With magic, you can turn a frog into a prince
With science, you can turn a frog into a Ph.D
and you still have the frog you started with
(Sir Terry Pratchett)
4
Luca Faoro
This presentation represent my own opinion and does not necessarily reflect Novartis’ opinion/view
5
Che cosa mi interessa
6
Luca Faoro
Ho 45 anni, sposato, 2 figli
Sono un Biologo
Lavoro da 18 anni
Ho lavorato per 8 aziende, in Italia e all’estero
Parlo 3 lingue (ma ne vorrei parlare altre 3!)
Sono stato promosso ma anche licenziato
Ho gestito persone
7
Perchè parliamo di farmaco e
di lavorare
nella ricerca clinica?
This presentation represent my own opinion and does not necessarily reflect Novartis’ opinion/view
8
Alcuni numeri del farmaceutico e del suo indotto in Italia
This presentation represent my own opinion and does not necessarily reflect Novartis’ opinion/view
9
Project Manager
Site Contracts
Managers
Assoc. Project Manager
Project Director
Business Development
Global Regulatory Affairs
Clinical Operations
Medical Expert
BiostatisticianData Manager
ProgrammersDM TeamEDC
Dev. Team
Lead SMA
SMA Team
Lead CRA
CRAs Legal Team
Scientific Lead
Research
Associate
CTS Lead
Project Coordinators
Esempio di un Team di Progetto per uno Studio Clinico
This presentation represent my own opinion and does not necessarily reflect Novartis’ opinion/view
10
Laboratori, Aziende e CRO
Fare ricerca in un Istituto o in Azienda
Lavorare in uno dei tanti settori del Famaceutico
Le Contract Research Organization (CRO)
Clinical Research Associate
L’addetto di Farmacovilanza
Il Medical Liaison/Medical Advisor
Il Product Manager
L’Informatore Scientifico del Farmaco
Il Data Manager
This presentation represent my own opinion and does not necessarily reflect Novartis’ opinion/view
11
Digital Health
This presentation represent my own opinion and does not necessarily reflect Novartis’ opinion/view
12
Importanza delle Lingue Straniere (almeno l’inglese)
Cercate di capire cosa volete fare «da grandi»
Se indecisi, andate a lavorare!
Sviluppate anche le vostre ”Soft skills”
Qualche consiglio
This presentation represent my own opinion and does not necessarily reflect Novartis’ opinion/view
13
Nations represented in my office
Italy
France
Germany
Poland
Cyprus
China
Greece
Peru
Romania
Sweden
Pakistan
This presentation represent my own opinion and does not necessarily reflect Novartis’ opinion/view
14
Estero: lavorare in una casa madre?
This presentation represent my own opinion and does not necessarily reflect Novartis’ opinion/view
15
Per saperne di più…
Alla ricerca del farmaco perduto
Carlo Tomino
Ed. Medi Service
Guida alla ricerca clinica
Ugo Lancia
Ed. Pensiero Scientifico
This presentation represent my own opinion and does not necessarily reflect Novartis’ opinion/view
16
Domande?
Arrivederci!
17
Back Up Slides
18
Dopo l’Università?
This presentation represent my own opinion and does not necessarily reflect Novartis’ opinion/view
19
Master in discipline regolatorie
This presentation represent my own opinion and does not necessarily reflect Novartis’ opinion/view
20
Master in ricerca clinica/sviluppo dei farmaci
Master di II livello: Sviluppo preclinico e
clinico del farmaco: aspetti tecnico-
scientifici, regolatori ed etici
Master di II livello in Ricerca e
Sviluppo Pre-clinico e Clinico
dei Farmaci
This presentation represent my own opinion and does not necessarily reflect Novartis’ opinion/view
21
Stretegic ResearchHugo Stephenson
Ed. Quintiles Transnational
Registries for Evaluating Patient Outcomes:
A User’s GuideAgency for Healthcare Research and Quality
http://effectivehealthcare.ahrq.gov/index.cfm/search-for-guides
-reviews-and-reports/?
productid=1897&pageaction=displayproduct
This presentation represent my own opinion and does not necessarily reflect Novartis’ opinion/view
22
PharmaTrain
www.pharmatrain.eu
This presentation represent my own opinion and does not necessarily reflect Novartis’ opinion/view
23
Alcune considerazioni
Avete un diverso assetto formativo rispetto al passato - ad es. laurea che ora è 3+2 – e rispetto ai vostri colleghi europei
Si lavora in un contesto europeo ma sempre piu’ globale
Vi sono nuove aree di specializzazione Health Tecnology Assessment
Late Phase
Rare Diseases
Digital Health
This presentation represent my own opinion and does not necessarily reflect Novartis’ opinion/view
24
Scegliete con cura la vostra specializzazione
Valutate e informatevi sulle alternative che avete
MBA (Master in Business Administration)
Project Management Institute
Corsi/Stage offerti da Società Scientifiche
(SIF, AFI, SSFA)
Master post-laurea(Milano, Pavia, Roma, Firenze)
Se volete continuare a studiare
This presentation represent my own opinion and does not necessarily reflect Novartis’ opinion/view
25
Internet & i social
This presentation represent my own opinion and does not necessarily reflect Novartis’ opinion/view
26
Trends attuali
This presentation represent my own opinion and does not necessarily reflect Novartis’ opinion/view
27
0
200
400
600
800
1000
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012
Interventional Studies in Italy
La Sperimentazione Clinica dei Medicinali in Italia 2013
Studi Clinici In Italia
28
Studi Clinici per area
This presentation represent my own opinion and does not necessarily reflect Novartis’ opinion/view
29
Prodotti per Area Terapeutica
This presentation represent my own opinion and does not necessarily reflect Novartis’ opinion/view
30
Il Biotech
Indicatori Farmaceutici - Farmindustria, 2013
This presentation represent my own opinion and does not necessarily reflect Novartis’ opinion/view
31
Pipeline nel Biotech
This presentation represent my own opinion and does not necessarily reflect Novartis’ opinion/view
32
0
20
40
60
80
100
120
140
160
180
200
2010 2011 2012
Observational Studies in Italy
La Sperimentazione Clinica dei Medicinali in Italia 2013
This presentation represent my own opinion and does not necessarily reflect Novartis’ opinion/view
33
33
Gli Studi Post-Marketing
A fronte di requisiti regolatori
sempre maggiori, il numero di
studi di phase IV continua a
crescere
2.83.2
3.8
4.3
5.0
5.7
$0.0
$1.0
$2.0
$3.0
$4.0
$5.0
$6.0
2006 2007 2008 2009 2010 2011
Phase IIIb/IV CRO Market
Opportunity (in billions)
Source: Goldman Sachs, December 3, 2007.
This presentation represent my own opinion and does not necessarily reflect Novartis’ opinion/view
34
Classifica dei 10 mercati farmaceutici piu’ importanti
This presentation represent my own opinion and does not necessarily reflect Novartis’ opinion/view
35
Quali opportunità di lavoro?
(e dove cercarle)
This presentation represent my own opinion and does not necessarily reflect Novartis’ opinion/view
36
Indicatori Farmaceutici - Farmindustria, 2016
Dove c’è lavoro?
This presentation represent my own opinion and does not necessarily reflect Novartis’ opinion/view
37
Industria farmaceutica in Italia (milioni di euro, dati al 31 dicembre)
Industria farmaceutica in Italia
(milioni di euro, dati al 31 dicembre)
This presentation represent my own opinion and does not necessarily reflect Novartis’ opinion/view
38
Indicatori Farmaceutici - Farmindustria, 2016
Occupazione per titolo di studio (% sul totale)
This presentation represent my own opinion and does not necessarily reflect Novartis’ opinion/view
39
Indicatori Farmaceutici - Farmindustria, 2016
Caratteristiche dell’occupazione (% sul totale)
This presentation represent my own opinion and does not necessarily reflect Novartis’ opinion/view
40
Caratteristiche dell'occupazione in Ricerca e Sviluppo
Indicatori Farmaceutici - Farmindustria, 2013This presentation represent my own opinion and does not necessarily reflect Novartis’ opinion/view
41Indicatori Farmaceutici - Farmindustria, 2013
Occupazione per genere e categoria (% sul totale)
42Indicatori Farmaceutici - Farmindustria, 2013
E se siete donna?
This presentation represent my own opinion and does not necessarily reflect Novartis’ opinion/view
43This presentation represent my own opinion and does not necessarily reflect Novartis’ opinion/viewIndicatori Farmaceutici - Farmindustria, 2016
Le aziende si occupano di me?
44
Ma si puo’ guadagnare bene?
This presentation represent my own opinion and does not necessarily reflect Novartis’ opinion/view